This company has been marked as potentially delisted and may not be actively trading. Accolade (ACCD) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Get the Latest News and Ratings for ACCD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Accolade and its competitors. Enter your email to sign up for newsletter Sign Up ACCD Analyst Ratings Over TimeTypeCurrent Forecast7/16/24 to 7/16/251 Month Ago6/16/24 to 6/16/253 Months Ago4/17/24 to 4/17/251 Year Ago7/17/23 to 7/16/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)1 Buy rating(s)1 Buy rating(s)12 Buy rating(s)Hold13 Hold rating(s)13 Hold rating(s)13 Hold rating(s)3 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$6.57$6.51$6.51$11.65Forecasted Upside-6.41% Downside-7.31% Downside-7.31% Downside195.03% UpsideConsensus RatingHoldHoldHoldModerate Buy ACCD Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History ACCD Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Accolade Stock vs. The CompetitionTypeAccoladeBusiness Services CompaniesS&P 500Consensus Rating Score 2.00 2.73 2.53Consensus RatingHoldModerate BuyModerate BuyPredicted Upside-6.41% Downside386.01% Upside12.41% UpsideNews Sentiment RatingNeutral NewsSee Recent ACCD NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/5/2025Piper Sandler2 of 5 starsJ. TassanSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold2/12/2025Stephens4 of 5 starsJ. GarroSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$7.03 ➝ $7.03+1.96%1/10/2025Truist Financial3 of 5 starsJ. SinghSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold1/9/2025Stifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Hold$8.00 ➝ $7.03+2.48%1/9/2025Raymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingOutperform ➝ Market Perform1/8/2025William BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. DanielsSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold1/8/2025Leerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. ChernySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold1/8/2025Canaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. CloseSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold1/8/2025Needham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingR. MacdonaldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold1/8/2025Leerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingOutperform ➝ Market Perform Get the Latest News and Ratings for ACCD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Accolade and its competitors with MarketBeat's FREE daily newsletter. 12/17/2024Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetEqual Weight ➝ Equal Weight$6.00 ➝ $5.00+44.51%10/11/2024Wells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetEqual Weight ➝ Equal Weight$7.00 ➝ $6.00+59.57%10/9/2024BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetEqual Weight ➝ Equal Weight$5.50 ➝ $5.00+22.25%6/28/2024GuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetBuy ➝ Buy$13.00 ➝ $6.00+63.49%12/6/2023DA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingG. LuriaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy10/5/2023Bank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower Target$19.00 ➝ $16.00+64.10%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:17 AM ET. ACCD Forecast - Frequently Asked Questions What is Accolade's forecast for 2025? According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Accolade is $6.57, with a high forecast of $8.00 and a low forecast of $5.00. Should I buy or sell Accolade stock right now? 13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Accolade in the last year. There are currently 13 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ACCD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACCD, but not buy additional shares or sell existing shares. Does Accolade's stock price have much downside? According to analysts, Accolade's stock has a predicted downside of -6.41% based on their 12-month stock forecasts. Do Wall Street analysts like Accolade more than its competitors? Analysts like Accolade less than other "business services" companies. The consensus rating for Accolade is Hold while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how ACCD compares to other companies. Stock Forecasts and Research Tools Related Companies EVTC Stock Forecast APLD Stock Forecast RAMP Stock Forecast FIVN Stock Forecast DFIN Stock Forecast PLTK Stock Forecast PINC Stock Forecast GDRX Stock Forecast UPWK Stock Forecast XMTR Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:ACCD) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accolade, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accolade With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
